Reply to: "Interferon-free therapy of hepatitis C during wait list and post transplant risk of hepatocellular carcinoma recurrence"

被引：0
|
作者：
Yang, Ju Dong [1 ]
Leise, Michael D. [1 ]
机构：
[1] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 67卷 / 06期
关键词：
SOFOSBUVIR PLUS RIBAVIRIN; ADVANCED LIVER-DISEASE; LEDIPASVIR; INFECTION;
D O I：
10.1016/j.jhep.2017.08.001
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1357 / 1357
页数：1
相关论文
共 50 条
  • [1] Interferon-free therapy of hepatitis C during wait list and post-transplant risk of hepatocellular carcinoma recurrence
    Donato, Maria Francesca
    Invernizzi, Federica
    Rossi, Giorgio
    Iavarone, Massimo
    JOURNAL OF HEPATOLOGY, 2017, 67 (06) : 1355 - 1356
  • [2] Interferon-Free Therapy for Hepatitis C in Liver Transplant Recipients
    Ueda, Yoshihide
    Uemoto, Shinji
    TRANSPLANTATION, 2016, 100 (01) : 54 - 60
  • [3] Risk of recurrence of hepatocellular carcinoma in patients treated with interferon-free antivirals
    Hernaez-Alsina, Tania
    Caballol-Oliva, Berta
    Diaz-Gonzalez, Alvaro
    Guedes-Leal, Cassia
    Reig, Maria
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2019, 42 (08): : 502 - 511
  • [4] INTERFERON-FREE THERAPY IS NOT A TRIGGER FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC INFECTION WITH HEPATITIS C VIRUS
    Suceveanu, Andra-Iulia
    Stoian, Anca Pantea
    Mazilu, Laura
    Voinea, Felix
    Hainarosie, Razvan
    Diaconu, Camelia Cristina
    Pituru, Silviu
    Nitipir, Cornelia
    Badiu, Dumitru Cristinel
    Ceausu, Iuliana
    Suceveanu, Adrian Paul
    FARMACIA, 2018, 66 (05) : 904 - 908
  • [5] Interferon-Free Hepatitis C Virus Therapy
    Pawlotsky, Jean-Michel
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2020, 10 (11): : 1 - 13
  • [6] Reply to: "Treatment failure after interferon-free treatment of hepatitis C as a clue of a yet undetected hepatocellular carcinoma"
    Prenner, Stacey
    Kulik, Laura
    JOURNAL OF HEPATOLOGY, 2018, 68 (01) : 213 - 214
  • [7] Watch and wait - chronic hepatitis C patients before the era of interferon-free therapy in Germany
    Hueppe, D.
    Buggisch, P.
    Christensen, S.
    Heiken, H.
    Mauss, S.
    Naumann, U.
    Fischer, C.
    Kleine, H.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 22 - 23
  • [8] Interferon-free direct-acting antiviral therapy decreases the rate of hepatocellular carcinoma recurrence in patients with chronic hepatitis C and advanced fibrosis
    Virlogeux, V.
    Pradat, P.
    Hartig-Lavie, K.
    Bailly, F.
    Maynard, M.
    Ouziel, G.
    Poinsot, D.
    Lebosse, F.
    Ecochard, M.
    Radenne, S.
    Benmakhlouf, S.
    Koffi, J.
    Lack, P.
    Scholtes, C.
    Uhres, A. -C.
    Ducerf, C.
    Mabrut, J. -Y.
    Rode, A.
    Levrero, M.
    Combet, C.
    Merle, P.
    Zoulim, F.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S745 - S745
  • [9] High incidence of hepatocellular carcinoma following successful interferon-free antiviral therapy for hepatitis C associated cirrhosis
    Cardoso, Helder
    Vale, Ana
    Rodrigues, Susana
    Goncalves, Regina
    Albuquerque, Andreia
    Pereira, Pedro N.
    Lopes, Susana
    Silva, Marco
    Andrade, Patricia
    Morais, Rui
    Coelho, Rosa
    Macedo, Guilherme
    HEPATOLOGY, 2016, 64 : 663A - 663A
  • [10] Analyzing risk factors and developing a stratification system for hepatocellular carcinoma recurrence after interferon-free direct-acting antiviral therapy in chronic hepatitis C patients
    Luan, Chih-Hsuan
    Su, Pin-Shuo
    Chu, Chi-Jen
    Lin, Chung-Chi
    Su, Chien-Wei
    Luo, Jiing-Chyuan
    Lee, I-Cheng
    Chi, Chen-Ta
    Lee, Shou-Dong
    Wang, Yuan-Jen
    Lee, Fa-Yauh
    Huang, Yi-Hsiang
    Hou, Ming-Chih
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2024, 87 (04) : 357 - 368
12345